Literature DB >> 34333039

Patient Satisfaction with Telephone Versus Video- Televisits: A Cross-Sectional Survey of an Urban, Multiethnic Population.

Ariel Z Allen1, Denzel Zhu1, Christina Shin1, Deborah T Glassman2, Nitya Abraham3, Kara L Watts4.   

Abstract

OBJECTIVE: To examine differences between telephone- and video-televisits and identify whether visit modality is associated with satisfaction in an urban, academic general urology practice.
METHODS: A cross-sectional analysis of patients who completed a televisit at our urology practice (summer 2020) was performed. A Likert-based satisfaction telephone survey was offered to patients within 7 days of their televisit. Patient demographics, televisit modality (telephone vs video), and outcomes of the visit (e.g. follow-up visit scheduled, orders placed) were retrospectively abstracted from each chart and compared between the telephone and video cohorts. Multivariate regression analysis was used to evaluate variables associated with satisfaction while controlling for potential confounders.
RESULTS: 269 patients were analyzed. 73% (196/269) completed a telephone televisit. Compared to the video cohort, the telephone cohort was slightly older (mean 58.8 years vs. 54.2 years, p=0.03). There were no significant differences in the frequency of orders placed for medication changes, labs, imaging, or for in-person follow-up visits within 30-days between cohorts. Survey results showed overall 84.7% patients were satisfied, and there was no significant difference between the telephone and video cohorts. Visit type was not associated with satisfaction on multivariable analyses, while use of an interpreter [OR:8.13 (1.00-65.94); p=0.05], labs ordered [OR:2.74 (1.12-6.70); p=0.03] and female patient gender [OR:2.28 (1.03-5.03); p=0.04] were significantly associated with satisfaction.
CONCLUSIONS: Overall, most patients were satisfied with their televisit. Additionally, telephone- and video-televisits were similar regarding patient opinions, patient characteristics, and visit outcome. Efforts to increase access and coverage of telehealth, particularly telephone-televisits, should continue past the COVID-19 pandemic.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Hispanic; multiethnic; non-Hispanic Black; non-Hispanic White; out-patient; telehealth; telemedicine; telephone; urology; video

Year:  2021        PMID: 34333039     DOI: 10.1016/j.urology.2021.05.096

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

1.  Provider and Patient Satisfaction with Telemedicine Voice Therapy During the COVID-19 Pandemic.

Authors:  Mary E Kim; Lauren Timmons Sund; Mariah Morton; James Kim; Janet S Choi; M Eugenia Castro
Journal:  J Voice       Date:  2022-07-18       Impact factor: 2.300

2.  Pilot trial of telemedicine in urology: Video vs. telephone consultations.

Authors:  David-Dan Nguyen; Anne Xuan-Lan Nguyen; David Bouhadana; Kahina Bensaadi; François Peloquin; Jean-Baptiste Lattouf; Daniel Liberman; Manon Choinière; Naeem Bhojani
Journal:  Can Urol Assoc J       Date:  2022-04       Impact factor: 2.052

3.  Cancer Patients' Experiences with Telehealth before and during the COVID-19 Pandemic in British Columbia.

Authors:  Sara Izadi-Najafabadi; Lisa McQuarrie; Stuart Peacock; Ross Halperin; Leah Lambert; Craig Mitton; Helen McTaggart-Cowan
Journal:  Curr Oncol       Date:  2022-06-10       Impact factor: 3.109

Review 4.  The impact of COVID-19 on urology office visits and adoption of telemedicine services.

Authors:  Mohit Butaney; Amarnath Rambhatla
Journal:  Curr Opin Urol       Date:  2022-03-01       Impact factor: 2.309

5.  The telehealth divide: health inequity during the COVID-19 pandemic.

Authors:  Katie Fisher; Parker Magin
Journal:  Fam Pract       Date:  2022-05-28       Impact factor: 2.290

6.  Patient satisfaction with telehealth versus in-person visits during COVID-19 at a large, public healthcare system.

Authors:  Kevin Chen; Komal Lodaria; Hannah B Jackson
Journal:  J Eval Clin Pract       Date:  2022-09-22       Impact factor: 2.336

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.